Draconis Pharma

Barcelona, Spain Founded: 2011 • Age: 15 yrs
Therapeutic solutions for cancer, pain, and immune diseases are developed.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Draconis Pharma

Draconis Pharma is a company based in Barcelona (Spain) founded in 2011. Draconis Pharma operates in a competitive market with competitors including Aclaris Therapeutics, Denali Therapeutics, Escient Pharmaceuticals, Flexion Therapeutics and Poseida Therapeutics, among others.

  • Headquarter Barcelona, Spain
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Draconis Pharma

Premium access

Detailed funding history for Draconis Pharma

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Draconis Pharma

Investments
Premium access

Investment portfolio details for Draconis Pharma

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Draconis Pharma

Premium access

Detailed financials for Draconis Pharma

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Draconis Pharma Comparisons

Draconis Pharma Primary company
Description
Therapeutic solutions for cancer, pain, and immune diseases ...
Location
Barcelona, Spain
Founded Year
2011
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Draconis Pharma

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Draconis Pharma

Draconis Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aclaris Therapeutics, Denali Therapeutics, Escient Pharmaceuticals, Flexion Therapeutics and Poseida Therapeutics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Novel dermatologic therapies are developed for skin conditions.
Locked Locked Locked
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
Locked Locked Locked
Small molecule therapeutics for inflammatory diseases are developed.
Locked Locked Locked
Developer of therapies for the treatment of musculoskeletal disorders
Locked Locked Locked
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
Locked Locked Locked
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
Premium access

Detailed competitors of Draconis Pharma

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Draconis Pharma

Premium access

Complete news archive for Draconis Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Draconis Pharma

Draconis Pharma was founded in 2011.

Draconis Pharma is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.

Founded in 2011 and based in Barcelona, Spain, Draconis Pharma operates in the pharmaceutical sector. Therapeutic solutions are developed for immune-based conditions including inflammation, autoimmunity, allergy, cancer, and pain. Efficacy, safety, and toxicology of compounds such as small molecules, proteins, antibodies, RNA-based therapies, vaccines, functional foods, and probiotics are evaluated. Drug solutions targeting EP4 receptor antagonism for immune response modulation have been advanced.

Draconis Pharma's top competitors include Juno Therapeutics, Flexion Therapeutics and Escient Pharmaceuticals.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available